Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 14 January 2026

Fiserv stock edges up as Clover lands CareCredit expansion — here’s what traders watch next

Fiserv stock edges up as Clover lands CareCredit expansion — here’s what traders watch next

New York, January 14, 2026, 15:08 EST — Regular session Fiserv shares edged up Wednesday afternoon, hitting $66.81, even as the S&P 500 ETF slipped roughly 0.8%. The move was modest, yet the situation remains fragile. Fiserv is working to regain trust after slashing its outlook and shaking up leadership in October, which sparked a record one-day plunge in its stock. Broader markets dragged lower again. Wall Street’s key indexes dropped for a second day while investors digested patchy results from major banks. “It’s not unusual to see a little bit of a pullback,” said Jake Johnston, deputy CIO at
14 January 2026
········
Amphenol stock pulls back from record run as $10.5 billion CommScope deal sinks in

Amphenol stock pulls back from record run as $10.5 billion CommScope deal sinks in

New York, Jan 14, 2026, 15:02 EST — Regular session Shares of Amphenol Corp (APH.N) dipped Wednesday, retreating from a three-day surge that had lifted the connector maker to a fresh 52-week peak just a day earlier. The stock slipped roughly 1.8% to $146.30 in afternoon trading, following a 2.7% gain to $148.97 on Tuesday. Earlier in the session, it hit $149.56. (MarketWatch) The retreat follows investors’ shift in focus to Amphenol’s recent $10.5 billion all-cash acquisition of CommScope’s Connectivity and Cable Solutions (CCS) unit. This deal significantly alters the company’s sales profile and heightens execution risk. An SEC filing
14 January 2026
····
Wells Fargo stock slides 5% after earnings miss and light 2026 interest-income outlook

Wells Fargo stock slides 5% after earnings miss and light 2026 interest-income outlook

NEW YORK, Jan 14, 2026, 14:02 EST — Regular session Wells Fargo (WFC) shares dropped 5.1% to $88.81 in Wednesday afternoon trading. The bank missed profit estimates for the quarter and projected 2026 net interest income below Wall Street forecasts. (Reuters) The decline signals a warning for U.S. financials just as earnings season kicks off, with investors gauging how much of last year’s bank rally hinged on cleaner earnings versus simpler year-over-year comparisons. Wells Fargo is the first major report since regulators removed its long-standing asset cap, opening the door for growth. That raises the stakes, not lowers them, as
14 January 2026
·····
KLA stock slips despite fresh Wall Street upgrades — here’s what’s driving KLAC now

KLA stock slips despite fresh Wall Street upgrades — here’s what’s driving KLAC now

New York, January 14, 2026, 13:36 EST — Regular session KLA Corp shares dipped Wednesday despite a string of positive analyst notes, as investors stepped away from semiconductor equipment stocks during a weaker session. The stock fell 1.7% to $1,417.18 in early afternoon trading. Timing is key. KLA has turned into a popular pick for those betting on increased spending in advanced chips, where inspection and measurement gear grow in importance as designs shrink and defects become pricier. The pullback mirrored weakness across the broader market, as investors digested bank earnings alongside new policy jitters. “Banks have had a very
14 January 2026
·····
Edgewise Therapeutics stock jumps about 11% on 2026 trial calendar — what’s next for EWTX

Edgewise Therapeutics stock jumps about 11% on 2026 trial calendar — what’s next for EWTX

New York, Jan 14, 2026, 12:55 (EST) — Regular session Shares of Edgewise Therapeutics Inc (EWTX.O) were up 10.6% at $27.59 by 12:55 p.m. EST on Wednesday after the drug developer laid out a 2026 schedule for clinical readouts and trial starts across its muscle-disease and cardiac pipeline. The move matters because Edgewise is still pre-commercial, and its valuation hangs on when — and how cleanly — the next sets of data arrive. In biotech, dates can trade almost like earnings. Edgewise used the J.P. Morgan Healthcare Conference this week to tighten up its roadmap, giving investors a clearer sequence
14 January 2026
·····
Spotify stock slides after Bernstein slashes target to $650 as AI push hits valuation nerves

Spotify stock slides after Bernstein slashes target to $650 as AI push hits valuation nerves

New York, Jan 14, 2026, 12:57 EST — Regular session Shares of Spotify Technology S.A. dropped 2.5% to $521.28 in early afternoon trading Wednesday, deepening a recent slide after Bernstein lowered its price target for the music-streaming giant. The Invesco QQQ Trust, an ETF tracking the Nasdaq-100, slipped roughly 1.7%. Spotify’s new leadership is pushing the idea that artificial intelligence can boost listener engagement without draining resources. “AI isn’t about automation … it’s about agency,” co-CEOs Alex Norström and Gustav Söderström said, highlighting tools like Prompted Playlist, DJ requests, and Mixing. (Spotify) Spotify, set to release its quarterly earnings on
14 January 2026
····
Wells Fargo stock slides nearly 6% after earnings miss, as 2026 outlook sharpens focus

Wells Fargo stock slides nearly 6% after earnings miss, as 2026 outlook sharpens focus

New York, Jan 14, 2026, 12:24 EST — Regular session Wells Fargo & Company shares slid 5.7% to $88.27 in New York on Wednesday, deepening the sell-off following its quarterly earnings release and new 2026 goals. Investors are zeroing in on two key issues for big banks: how rising rates will impact loan earnings, and if cost-cutting is finally within reach after years of heavy compliance spending. Wells Fargo, in particular, is eager to show it can expand more aggressively now that regulators have removed its longstanding balance sheet cap. Wells Fargo reported fourth-quarter net income of $5.36 billion, or
14 January 2026
·····
Roblox stock (RBLX) slips after Tuesday pop as Morgan Stanley trims target and insider sale filing surfaces

Roblox stock (RBLX) slips after Tuesday pop as Morgan Stanley trims target and insider sale filing surfaces

New York, January 14, 2026, 12:10 PM EST — Regular session. Roblox Corp shares were down about 1.2% at $83.75 in midday trading on Wednesday, giving back some of a sharp jump a day earlier. The stock rose 10.5% on Tuesday to close at $84.80, with volume far above its recent pace. (Investing.com) The pullback lands as investors reset for Roblox’s next results, due after the market close on Feb. 5, with a conference call scheduled for 4:30 p.m. EST. Attention is on bookings — a measure that tracks sales of Robux and other in-platform spending before it flows into
14 January 2026
····
Bank of America (BAC) stock slides after earnings as Wall Street parses interest income outlook

Bank of America (BAC) stock slides after earnings as Wall Street parses interest income outlook

New York, Jan 14, 2026, 11:47 EST — Regular session Bank of America shares dropped roughly 4% to $52.37 on Wednesday, slipping back after initially rising post-earnings. JPMorgan, Citigroup, and Wells Fargo also fell. This shift is significant as major U.S. banks are leading the earnings season, with investors closely watching rate-sensitive lenders for signs on margins, loan demand, and consumer resilience. Markets remain jittery over the next move in interest rates. “Banks have had a very strong start to the year and markets are taking a little time to digest,” said Jake Johnston, deputy CIO at Advisors Asset Management,
14 January 2026
····
Eli Lilly stock slips as FDA drops suicide warning for Zepbound; traders eye orforglipron, earnings next

Eli Lilly stock slips as FDA drops suicide warning for Zepbound; traders eye orforglipron, earnings next

New York, Jan 14, 2026, 11:40 AM EST — Regular session Eli Lilly and Company shares slipped Wednesday following a move by U.S. regulators to remove suicide-related warnings from several popular obesity drugs, including Lilly’s Zepbound. The stock was down roughly 0.4%, trading near $1,072.89 by late morning. (U.S. Food and Drug Administration) The label change is significant because it addresses a major safety concern that’s been dogging weight-loss drugs, even as demand remains robust and politicians and insurers press on prices. For Lilly, obesity remains the key driver in the stock, and anything that cuts “headline risk” usually gets
14 January 2026
·····
Intel stock steadies after KeyBanc upgrade sparks AI-server demand debate

Intel stock steadies after KeyBanc upgrade sparks AI-server demand debate

New York, January 14, 2026, 10:28 AM EST — Regular session Intel shares climbed 1.4% to $47.94 on Wednesday, retreating slightly from an earlier surge but holding steady after a big jump the previous day. So far, the stock has fluctuated between $47.56 and $49.41 during the session. KeyBanc upgraded Intel to “overweight,” signaling the firm expects it to outperform peers, citing stronger-than-anticipated demand for server CPUs—the chips powering data centers. The broker also raised Advanced Micro Devices, noting that both companies seem “largely sold out” of their expected 2026 capacity and could boost prices by 10% to 15%. (Investopedia)
14 January 2026
·····
Natural Gas Services Group stock is back on the analyst tape — what to watch for NGS next

Natural Gas Services Group stock is back on the analyst tape — what to watch for NGS next

New York, Jan 14, 2026, 10:22 ET — Regular session. Shares of Natural Gas Services Group edged up roughly 0.2% to $34.26 Wednesday morning, despite recent downgrades from analysts at Zacks and Raymond James over the last two days. The timing is key since the stock has hovered close to its one-year peak. The recent calls underline a common friction: solid operational momentum against a price that’s already pushed higher. Zacks downgraded its rating from “strong-buy” to “hold,” MarketBeat reported. (MarketBeat) On Tuesday, Raymond James shifted gears with Natural Gas Services Group, cutting its rating to “outperform” from “strong buy”
14 January 2026
·····
1 … 50 51 52 53 54 … 282

Stock Market Today

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

7 February 2026
PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

7 February 2026
Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
Go toTop